Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study

BACKGROUND: Our previous work has demonstrated the benefits of transcutaneous immunization in targeting Langerhans cells and preferentially inducing CD8 T-cell responses. METHODS: In this randomized phase Ib clinical trial including 20 HIV uninfected volunteers, we compared the safety and immunogeni...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Sanchez, Jorge, Gonçalves, Elena, Llano, Anuska, Gonzáles, Pedro, Fernández-Maldonado, María, Vogt, Annika, Soria, Angele, Perez, Susana, Cedeño, Samandhy, Fernández, Marco Antonio, Nourikyan, Julien, de Bernard, Simon, Ganoza, Carmela, Pedruzzi, Eric, Bonduelle, Olivia, Mothe, Beatriz, Gòmez, Carmen E., Esteban, Mariano, Garcia, Felipe, Lama, Javier R., Brander, Christian, Combadiere, Behazine
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7683801/
https://ncbi.nlm.nih.gov/pubmed/33244316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.586124
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi